S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
Log in

NASDAQ:VTVTvTv Therapeutics SEC Filings & 10K Form

$1.96
+0.04 (+2.08 %)
(As of 04/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.89
Now: $1.96
$2.03
50-Day Range
$1.63
MA: $2.43
$3.75
52-Week Range
$1.23
Now: $1.96
$4.23
Volume138,400 shs
Average Volume796,147 shs
Market Capitalization$127.91 million
P/E RatioN/A
Dividend YieldN/A
Beta-2.41

SEC Filings

vTv Therapeutics (NASDAQ:VTVT) SEC Filings

DateFilerForm TypeView
04/07/2020
4:10 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2020
3:31 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
3:31 PM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
01/28/2020
3:30 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2020
3:30 PM
vTv Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/07/2020
3:30 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2020
3:16 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
3:15 PM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
12/23/2019
3:30 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2019
3:15 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
3:15 PM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
12/18/2019
3:30 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2019
3:16 PM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
12/18/2019
3:15 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2019
3:30 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
3:30 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2019
4:31 PM
vTv Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2019
6:11 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2019
6:13 AM
vTv Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
09/30/2019
3:52 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2019
3:31 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
3:25 PM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
09/18/2019
3:40 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
3:40 PM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
09/18/2019
3:30 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2019
3:30 PM
KOZLOV HERSH (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
3:29 PM
KOZLOV HERSH (Reporting)
vTv Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2019
5:59 AM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2019
3:42 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2019
3:39 PM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
09/11/2019
3:30 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2019
5:24 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
3:58 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2019
5:37 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
6:38 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
3:40 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
3:30 PM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
08/06/2019
3:30 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2019
3:32 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2019
3:31 PM
vTv Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2019
11:16 PM
vTv Therapeutics (Filer)
Form EFFECT
07/09/2019
3:35 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2019
3:30 PM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
07/09/2019
3:30 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2019
3:26 PM
vTv Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
07/05/2019
3:31 PM
vTv Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/26/2019
3:31 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2019
7:52 AM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
7:45 AM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
05/16/2019
8:10 AM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2019
6:54 AM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2019
6:52 AM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
05/01/2019
3:41 PM
vTv Therapeutics (Issuer)
Weiner Howard L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2019
3:41 PM
Spiegel Noel Joseph (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2019
3:41 PM
FRY JOHN A (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2019
7:57 AM
vTv Therapeutics (Filer)
Form 424B5
03/19/2019
8:27 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2019
4:42 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
4:28 PM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
03/15/2019
7:04 AM
vTv Therapeutics (Filer)
Form DEFA14A
03/15/2019
7:00 AM
vTv Therapeutics (Filer)
Form DEF 14A
03/11/2019
3:30 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2019
3:06 PM
KINDLER JEFFREY B (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2019
3:06 PM
HOWARD RUDY (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2019
3:06 PM
Holcombe Stephen L. (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
8:02 AM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2019
7:31 AM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2019
8:29 AM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
02/15/2019
8:27 AM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2019
3:31 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2019
3:30 PM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
01/30/2019
3:30 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2019
3:35 PM
FRANKLIN RESOURCES INC (Filed by)
vTv Therapeutics (Subject)
Form SC 13G/A
01/18/2019
3:35 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
3:30 PM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
01/18/2019
3:30 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
3:54 PM
vTv Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
12/27/2018
7:00 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2018
7:00 PM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
12/27/2018
7:00 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2018
3:31 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2018
3:30 PM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
12/11/2018
4:04 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2018
3:30 PM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
11/30/2018
3:30 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
3:30 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2018
4:30 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2018
4:28 PM
vTv Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2018
6:06 AM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
11/07/2018
5:55 AM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2018
5:37 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2018
4:26 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2018
4:11 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2018
3:14 PM
vTv Therapeutics (Filer)
Form CT ORDER
09/10/2018
4:46 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2018
4:29 PM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
09/10/2018
3:30 PM
vTv Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2018
5:51 PM
SAVAS PAUL G (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2018
3:50 PM
PERELMAN RONALD O (Reporting)
vTv Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2018
3:45 PM
MacAndrews & Forbes Inc. (Filed by)
vTv Therapeutics (Subject)
Form SC 13D/A
This page was last updated on 4/9/2020 by MarketBeat.com Staff

Featured Article: What are retained earnings?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel